ESCRS - PP25.07 - A Real World Registry Evaluation Of Satisfaction, Spectacle Independence And Vision Outcomes In English Patients Implanted With A Novel Wavefront-Shaping Presbyopia-Correcting Iol

A Real World Registry Evaluation Of Satisfaction, Spectacle Independence And Vision Outcomes In English Patients Implanted With A Novel Wavefront-Shaping Presbyopia-Correcting Iol

Published 2022 - 40th Congress of the ESCRS

Reference: PP25.07 | Type: Free paper | DOI: 10.82333/kx0z-zt53

Authors: Nigel Kirkpatrick* 1

1Newmedica,London,United Kingdom

Purpose

To report Real World patient satisfaction, spectacle independence, visual disturbances and vision outcomes with the AcrySof IQ Vivity and AcrySof IQ Vivity Toric Extended Vision IOL models DFT015, DFT215, DFT315, DFT415, and DFT515 in English patients evaluated through routine clinical practice.

Setting

Multicenter, ambispective registry study conducted in Europe, the UK, Australia and New Zealand evaluating the performance of bilaterally implanted AcrySof IQ Vivity and AcrySof IQ Vivity Toric IOL in a real world setting through routine clinical practice.

Methods

This is a sub-analysis of subjects enrolled from UK sites to date. After a minimum of 3 months post-op follow up per local clinical practice standards, subjects implanted with the AcrySof IQ Vivity and/or Vivity Toric IOL underwent subjective vision satisfaction and spectacle independence with validated PROMs questionnaires and patient reports of visual disturbances.  We present the second interim analysis of outcomes observed at the enrollment visit to date.

Results

Currently 44 subjects are enrolled from three UK sites of which 92.9% present with Binocular UCDVA ≥ 20/25. The need to wear glasses is low with subjects reporting never/rarely needing to wear eyeglasses in bright light to see up close 88.1%, at arm’s length 97.6% or far away 81.0%.  92.9% are satisfied with their sight, 97.1% report none/some difficulty with their sight in their everyday lives, 97.6% no difficulty seeing to engage in an activity/hobby of their interest and 92.9% no difficulty reading text in newspapers. Visual disturbances rates are low - No halos 92.9%, glare 85.7% or starbursts 95.2%  There are no unanticipated AEs to date.

Conclusions

In this first Real World assessment of patients bilaterally implanted in UK with the AcrySof IQ Vivity and AcrySof IQ Vivity Toric IOL suggests high levels of post-operative patient satisfaction with low needs to wearing spectacles and experiencing very low visual disturbances.